Skip to main content
SpringerLink
Log in

Inhibition of gonadotropic and ovarian function by intranasal administration of D-Ser (TBU)6-EA10-LHRH in normo-ovulatory women and patients with polycystic ovary disease

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

We investigated the effectiveness of D-Ser (TBU)6-EA10-LHRH (Buserelin) intranasally 600 μg/day given 6 times daily in desensitizing normal ovulatory women and patients with polycystic ovarian disease (PCOD) before initiation of ovarian stimulation for in vitro fertilization. We found that this regimen was sufficient to suppress the gonadotrophs in the normal women and in 8 out of 10 PCOD patients. In PCOD ovarian hormones became normal after Buserelin administration. Adrenal steroidogenesis was not affected by the GnRH agonist. We suggested that the frequency of administration of Buserelin was important to achieve a constant receptor binding and consequently a rapid desensitization. The choice of a monoclonal immunoradiometric assay for luteinizing hormone (LH) and follicle stimulating hormone (FSH) in association with the estradiol-benzoate provocation test were essential in evaluating desensitization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wildt L., Diedrich K., van de Ven H., Al Hasani S., Hubner H., Klasen R. Ovarian hyperstimulation for in vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotropins. Hum. Reprod. 1: 15, 1986.

    PubMed  CAS  Google Scholar 

  2. Smitz J., Devroey P., Braeckmans P., Camus M., Khan I. Staessen C., Van Waesberghe L., Wisanto A., Van Steirteghem A.C. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. Hum. Reprod. 2: 309, 1987.

    PubMed  CAS  Google Scholar 

  3. Fleming R., Haxton M.J., Hamilton M.P.R., McCune G.S., Black W.P., MacNaughton M.C., Coutts J.R.T. Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins. Br. J. Obstet. Gynaecol. 92: 369, 1985.

    Article  PubMed  CAS  Google Scholar 

  4. Sandow J., Jerabek-Sandow G., Krauss B., Stoll W. Metabolic and dispositional studies with GnRH analogs. In: Zatuchni G.I., Shelton J.D., Sciarra J.J. (Eds.), LHRH peptides as female and male contraceptives. Harper & Row, Philadelphia, 1982, p. 321.

    Google Scholar 

  5. Schiettecatte J., Van Waesberghe L., Callewaert M., Smitz J., Van Steirteghem A.C. Benefit of monoclonal immunoradiometric assays for LH and FSH for the endocrine investigation of infertile patients. Hum. Reprod. 2: 101, 1987 (Abstract).

    Google Scholar 

  6. Lemay A., Maheux R., Faure N., Jean C., Fazekas A.T.A. Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis. Fertil. Steril. 41: 863, 1984.

    PubMed  CAS  Google Scholar 

  7. Shaw R.W., Matte W. Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis Comparison of two dose regimens. Clin. Reprod. Fert. 4: 329, 1986.

    CAS  Google Scholar 

  8. Peckham W.D., Knobil E. The effects of ovariectomy, estrogen replacement, and neuraminidase treatment on the properties of the adenohypophyseal glycoprotein hormones of the Rhesus monkey. Endocrinology 98: 1054, 1976.

    Article  PubMed  CAS  Google Scholar 

  9. Robertson D.M., Van Damme M.-P., Diczfalusy E. Biological and immunological characterization of human luteinizing hormone: I. Biological profile in pituitary and plasma samples after electrofocusing. Mol. Cell. Endocrinol. 9: 45, 1977.

    Article  PubMed  CAS  Google Scholar 

  10. Strollo F., Harlin J., Hernandez-Montez M., Robertson D.M., Zaidi A.A., Diczfalusy E. Qualitative and quantitative differences in the electrofocusing prof He of biologically active lutropin in the blood of normally menstruating and post-menopausal women. Acta Endocrinol. (Kbh.) 77: 655, 1981.

    Google Scholar 

  11. Evans R.M., Doelle J.C., Lindner J., Bradley V., Rabin D. A luteinizing hormone — releasing hormone agonist decreases biological activity and modifies chromatographic behaviour of luteinizing hormone in man. J. Clin. Invest. 73: 262, 1984.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  12. Bhasin S., Robinson R., Peterson M., Stein B.S., Handelman D., Rajfer J., Heber D., Swerdloff R.S. Molecular heterogeneity and biological activity of luteinizing hormone after gonadotropin-releasing hormone agonist treatment. Fertil. Steril. 42: 318, 1984 (Abstract).

    Google Scholar 

  13. Bettendorf G., Breandle W., Sprotte Ch., Poels W., Lichtenberg W., Lindner C. Pharmacologic hypogonadotropism — an advantage for hMG-induced follicular maturation and succeeding fertilisation. Horm. Metab. Res. 18: 656, 1986.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Reproductive Medicine, Academisch Ziekenhuis, Vrije Universiteit Brussels, Laarbeeklaan 101, B-1090, Brussels, Belgium

    J. Smitz, P. Devroey, M. Camus, J. Deschacht, L. Van Waesberghe, A. Wisanto & A. C. Van Steirteghem

Authors
  1. J. Smitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Devroey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Camus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Deschacht
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Van Waesberghe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Wisanto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. C. Van Steirteghem
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smitz, J., Devroey, P., Camus, M. et al. Inhibition of gonadotropic and ovarian function by intranasal administration of D-Ser (TBU)6-EA10-LHRH in normo-ovulatory women and patients with polycystic ovary disease. J Endocrinol Invest 11, 647–652 (1988). https://doi.org/10.1007/BF03350205

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350205

Key-words

Search

Navigation